SCHEMBL17344770

SCHEMBL17344770

CC(C)/C1=C(\C(C)C)c2ccccc2CCCN1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.40
PARP1 P09874 1/20 0.40
PARP10 Q53GL7 1/20 0.40
PARP11 Q9NR21 1/20 0.40
CYP2A6 P11509 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
ALOX12 P18054 1/20 0.35
HPGD P15428 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TSHR P16473 1/20 0.34
NOS3 P29474 1/20 0.34
DRD4 P21917 1/20 0.34
PRCP P42785 1/20 0.33
CES1 P23141 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17344764 0.90 PARP1 (0.50) PDPK1PARP1PARP10PARP11MAOB
SCHEMBL17344796 0.79 CA12 (0.47) PDPK1PARP1PARP10PARP11GAA
SCHEMBL17348445 0.70 PDPK1 (0.43) PDPK1PARP1PARP10PARP11CYP2A6
SCHEMBL18322825 0.69 PDPK1 (0.46) PDPK1PARP1PARP10PARP11CYP2A6
SCHEMBL1894080 0.69 PARP10 (0.78) PDPK1PARP1PARP10PARP11CYP2A6
SCHEMBL12797156 0.69 PDPK1 (0.46) PDPK1PARP1PARP10PARP11CYP2A6
SCHEMBL12797174 0.69 PARP1 (0.46) PDPK1PARP1PARP10PARP11CYP2A6
SCHEMBL19497057 0.69 PDPK1 (0.42) PDPK1PARP1PARP10PARP11CYP2A6
SCHEMBL17344788 0.69 NOS2 (0.33)
SCHEMBL17344765 0.68 ACHE (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150361093-A1 HIV REPLICATION INHIBITOR SHIONOGI & CO., LTD. (JP) 2015-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150361093-A1 HIV REPLICATION INHIBITOR RTF2, REV1, PCNA PDPK1 2056/4885PARP1 123/4885PARP10 109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.